To alleviate the dereplication holdup, which is a major bottleneck in natural products discovery, scientists have been conducting their research efforts to add tools to their “bag of tricks” aiming to achieve faster, more accurate and efficient ways to accelerate the pace of the drug discovery process.
29 December 2016 in Journal of Chemical Information and Modeling
Natural Products (NP) are essential for the discovery of novel drugs and products for numerous biotechnological applications. The NP discovery process is expensive and time-consuming, having as major hurdles dereplication (early identification of known compounds) and structure elucidation, particularly the determination of the absolute configuration of metabolites with stereogenic centers. This review comprehensively focuses on recent technological and instrumental advances, highlighting the development of methods that alleviate these obstacles, paving the way for accelerating NP discovery towards biotechnological applications. Herein, we emphasize the most innovative high-throughput tools and methods for advancing bioactivity screening, NP chemical analysis, dereplication, metabolite profiling, metabolomics, genome sequencing and/or genomics approaches, databases, bioinformatics, chemoinformatics, and three-dimensional NP structure elucidation.
Computational methodologies are assisting the exploration of marine natural products (MNPs) to make the discovery of new leads more efficient, to repurpose known MNPs, to target new metabolites on the basis of genome analysis, to reveal mechanisms of action, and to optimize leads. In silico efforts in drug discovery of NPs have mainly focused on two tasks: dereplication and prediction of bioactivities. The exploration of new chemical spaces and the application of predicted spectral data must be included in new approaches to select species, extracts, and growth conditions with maximum probabilities of medicinal chemistry novelty. In this review, the most relevant current computational dereplication methodologies are highlighted. Structure-based (SB) and ligand-based (LB) chemoinformatics approaches have become essential tools for the virtual screening of NPs either in small datasets of isolated compounds or in large-scale databases. The most common LB techniques include Quantitative Structure–Activity Relationships (QSAR), estimation of drug likeness, prediction of adsorption, distribution, metabolism, excretion, and toxicity (ADMET) properties, similarity searching, and pharmacophore identification. Analogously, molecular dynamics, docking and binding cavity analysis have been used in SB approaches. Their significance and achievements are the main focus of this review.
(2019). Have marine natural product drug discovery efforts been productive and how can we improve their efficiency?. Expert Opinion on Drug Discovery. Ahead of Print.
Machine learning (ML) algorithms were explored for the fast estimation of molecular dipole moments calculated by density functional theory (DFT) by B3LYP/6-31G(d,p) on the basis of molecular descriptors generated from DFT-optimized geometries and partial atomic charges obtained by empirical or ML schemes. A database was used with 10,071 structures, new molecular descriptors were designed and the models were validated with external test sets. Several ML algorithms were screened. Random forest regression models predicted an external test set of 3368 compounds achieving mean absolute error up to 0.44 D. The results represent a significant improvement of the dipole moments calculated using empirical point charges located at the nucleus, even assuming the DFT-optimized geometry (root mean square error, RMSE, of 0.68 D vs. 1.53 D and R2 = 0.87 vs. 0.66).